144 related articles for article (PubMed ID: 3656363)
1. Prodrugs of L-cysteine as protective agents against acetaminophen-induced hepatotoxicity. 2-(Polyhydroxyalkyl)- and 2-(polyacetoxyalkyl)thiazolidine-4(R)-carboxylic acids.
Roberts JC; Nagasawa HT; Zera RT; Fricke RF; Goon DJ
J Med Chem; 1987 Oct; 30(10):1891-6. PubMed ID: 3656363
[TBL] [Abstract][Full Text] [Related]
2. Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion.
Slitt AM; Dominick PK; Roberts JC; Cohen SD
Basic Clin Pharmacol Toxicol; 2005 Jun; 96(6):487-94. PubMed ID: 15910414
[TBL] [Abstract][Full Text] [Related]
3. 2-Substituted thiazolidine-4(R)-carboxylic acids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity.
Nagasawa HT; Goon DJ; Muldoon WP; Zera RT
J Med Chem; 1984 May; 27(5):591-6. PubMed ID: 6716397
[TBL] [Abstract][Full Text] [Related]
4. Protection against acetaminophen hepatotoxicity by ribose-cysteine (RibCys).
Roberts JC; Charyulu RL; Zera RT; Nagasawa HT
Pharmacol Toxicol; 1992 Apr; 70(4):281-5. PubMed ID: 1608914
[TBL] [Abstract][Full Text] [Related]
5. Double-prodrugs of L-cysteine: differential protection against acetaminophen-induced hepatotoxicity in mice.
Crankshaw DL; Berkeley LI; Cohen JF; Shirota FN; Nagasawa HT
J Biochem Mol Toxicol; 2002; 16(5):235-44. PubMed ID: 12439865
[TBL] [Abstract][Full Text] [Related]
6. Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys.
Roberts JC; Francetic DJ
Toxicol Lett; 1991 Dec; 59(1-3):245-51. PubMed ID: 1755032
[TBL] [Abstract][Full Text] [Related]
7. 2-Methyl-thiazolidine-2,4-dicarboxylic acid as prodrug of L-cysteine. Protection against paracetamol hepatotoxicity in mice.
Wlodek L; Rommelspacher H
Fundam Clin Pharmacol; 1997; 11(5):454-9. PubMed ID: 9342599
[TBL] [Abstract][Full Text] [Related]
8. Differential chemoprotection against acetaminophen-induced hepatotoxicity by latentiated L-cysteines.
Roberts JC; Phaneuf HL; Szakacs JG; Zera RT; Lamb JG; Franklin MR
Chem Res Toxicol; 1998 Nov; 11(11):1274-82. PubMed ID: 9815187
[TBL] [Abstract][Full Text] [Related]
9. L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.
Roberts JC; Francetic DJ; Zera RT
Cancer Chemother Pharmacol; 1991; 28(3):166-70. PubMed ID: 1855273
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of hepatic glutathione homeostasis and prevention of acetaminophen-induced cataract in mice by L-cysteine prodrugs.
Rathbun WB; Killen CE; Holleschau AM; Nagasawa HT
Biochem Pharmacol; 1996 May; 51(9):1111-6. PubMed ID: 8645331
[TBL] [Abstract][Full Text] [Related]
11. Thiazolidine prodrugs of cysteamine and cysteine as radioprotective agents.
Roberts JC; Koch KE; Detrick SR; Warters RL; Lubec G
Radiat Res; 1995 Aug; 143(2):203-13. PubMed ID: 7631013
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of paracetamol protective agents in mice in vivo.
Miners JO; Drew R; Birkett DJ
Biochem Pharmacol; 1984 Oct; 33(19):2995-3000. PubMed ID: 6487352
[TBL] [Abstract][Full Text] [Related]
13. Chemoprotection against cyclophosphamide-induced urotoxicity: ribose-cysteine.
Roberts JC; Francetic DJ
Anticancer Res; 1994; 14(2A):383-7. PubMed ID: 8017837
[TBL] [Abstract][Full Text] [Related]
14. Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis.
Williamson JM; Boettcher B; Meister A
Proc Natl Acad Sci U S A; 1982 Oct; 79(20):6246-9. PubMed ID: 6959113
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model.
Oz HS; Chen TS; Nagasawa H
Transl Res; 2007 Aug; 150(2):122-9. PubMed ID: 17656332
[TBL] [Abstract][Full Text] [Related]
16. Protection against acetaminophen-induced hepatotoxicity by L-CySSME and its N-acetyl and ethyl ester derivatives.
Nagasawa HT; Shoeman DW; Cohen JF; Rathbun WB
J Biochem Toxicol; 1996; 11(6):289-95. PubMed ID: 9176740
[TBL] [Abstract][Full Text] [Related]
17. Failure of glutathione and cysteine prodrugs to block the chlorpropamide-induced inhibition of aldehyde dehydrogenase in vivo.
Shirota FN; Elberling JA; Nagasawa HT; DeMaster EG
Biochem Pharmacol; 1992 Feb; 43(4):916-8. PubMed ID: 1540248
[TBL] [Abstract][Full Text] [Related]
18. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methylfuran.
Ravindranath V; Boyd MR
Biochem Pharmacol; 1991 May; 41(9):1311-8. PubMed ID: 2018563
[TBL] [Abstract][Full Text] [Related]
19. An HPLC radiotracer method for assessing the ability of L-cysteine prodrugs to maintain glutathione levels in the cultured rat lens.
Holleschau AM; Rathbun WB; Nagasawa HT
Curr Eye Res; 1996 May; 15(5):501-10. PubMed ID: 8724799
[TBL] [Abstract][Full Text] [Related]
20. The "pro-drug" RibCys decreases the mutagenicity of high-LET radiation in cultured mammalian cells.
Lenarczyk M; Ueno A; Vannais DB; Kraemer S; Kronenberg A; Roberts JC; Tatsumi K; Hei TK; Waldren CA
Radiat Res; 2003 Nov; 160(5):579-83. PubMed ID: 14565824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
